Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray

NCT ID: NCT04186806

Last Updated: 2024-10-02

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-02

Study Completion Date

2019-12-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the clinical trial is to evaluate and validate the performance of the experimental mouth spray when used by persons with mild to severe dry mouth symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to investigate the efficacy of 3M Dry Mouth Moisturizing Spray to reduce symptoms of dry mouth for up to 4 hours and after 7 days of use. In addition, this study aims to support comparative claims.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Xerostomia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

All subjects completing the wash-in procedures and meeting inclusion/exclusion criteria will undergo a pre-study 5-hour visit (the day before randomization) to assess the effect of water on their dry mouth symptoms. The subjects will return the next day for confirmation that inclusion/exclusion criteria and the wash-in procedures continue to be met or followed. Eligible subjects will be randomized at this baseline visit in a 1:1 ratio to one of two treatment orders: A-\>B (AB) or B-\>A (BA).
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

3M Dry Mouth Moisturizing Spray

Dry mouth agent

Group Type EXPERIMENTAL

3M Dry Mouth Moisturizing Spray to Biotene Moisturizing Mouth Spray

Intervention Type DEVICE

20 ml bottle

Biotene Moisturizing Mouth Spray to 3M Dry Mouth Moisturizing Spray

Intervention Type DEVICE

44.3 ml bottle

Biotene Moisturizing Mouth Spray

Dry mouth agent

Group Type ACTIVE_COMPARATOR

3M Dry Mouth Moisturizing Spray to Biotene Moisturizing Mouth Spray

Intervention Type DEVICE

20 ml bottle

Biotene Moisturizing Mouth Spray to 3M Dry Mouth Moisturizing Spray

Intervention Type DEVICE

44.3 ml bottle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3M Dry Mouth Moisturizing Spray to Biotene Moisturizing Mouth Spray

20 ml bottle

Intervention Type DEVICE

Biotene Moisturizing Mouth Spray to 3M Dry Mouth Moisturizing Spray

44.3 ml bottle

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Screening - Start of Wash-In Visit

* Subject who is ≥18 years of age and complains of dry mouth
* Only 1 subject per household is allowed into study
* Subject with a Challacombe scale score of 1 or higher
* Subject agrees to refrain from eating spicy foods and foods containing garlic beginning 48-hours prior to all study visits
* Subject agrees to eat a meal prior to all study visits that include sample evaluation in the clinic
* Subject agrees to not eat, drink, chew tobacco, chew gum, smoke, brush or floss teeth for 2-hours prior to sample evaluation study visits
* Subject agree to not use any oral care products and any type of breath mint or lozenges for 2-hours prior to sample evaluation study visits
* Subject agrees to refrain from any food and liquid during the 5-hour study visits except for what is provided by the study research staff (e.g., water and treatments A and B during evaluation periods)
* Subject agrees to only use those clinical oral care supplies provided during the entire study
* Able to understand and willing to sign the Informed Consent Form

Water Only Evaluation Visit

* Subject has successfully completed a ≥ 2-day wash-in period
* Subject has Challacombe scale score of 1 or higher
* Subject has refrained from eating spicy foods and foods containing garlic beginning 48-hours prior to the sample evaluation visits
* Subject ate a meal prior to sample evaluation study visits
* Subject has not eaten, drank, chewed tobacco, chewed gum, smoked, brushed or flossed teeth for 2-hours prior to sample evaluation study visits
* Subject has not used any oral care products, any type of breath mint or lozenges for 2-hours prior to sample evaluation study visits
* Subject agrees to refrain from any food and liquid during the 5-hour study visits except for what is provided by the study research staff (e.g., water and treatments A and B during evaluation periods)
* Subject has used only those clinical oral care supplies provided during study

Baseline Period 1/Randomization Visit

* Subject has successfully completed a ≥ 2-day wash-in period
* Subject has a Challacombe Scale score of 1 or higher
* Subject has refrained from eating spicy foods and foods containing garlic beginning 48-hours prior to sample evaluation study visits
* Subject ate a meal prior to sample evaluation study visits
* Subject has not eaten, drank, chewed tobacco, chewed gum, smoked, brushed or flossed teeth for 2-hours prior to sample evaluation study visits
* Subject has not used any oral care products and any type of breath mint or lozenges for 2-hours prior to sample evaluation study visits
* Subject agrees to refrain from any food and liquid during the 5-hour study visits except for what is provided by the study research staff (e.g., water and treatments A and B during evaluation periods)
* Subject has used only those clinical oral care supplies provided during study

Exclusion Criteria

* Subject has active mouth sores (e.g., cold sores, cuts, burns, canker sores)
* Subject has a life-threatening pathological condition
* Subject is participating in another clinical trial at the time of the study
* Subject has profound marginal periodontal disease (purulent exudate, tooth mobility, and/or extensive alveolar bone loss)
* Medical and oral conditions that, in the investigator's judgment, may compromise the subject's safety or interfere with the conduct and outcome of the study
* Difficult to be compliant with recalls, such as extensive travel commitments, lack of transportation etc.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

3M

INDUSTRY

Sponsor Role collaborator

Solventum US LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yiming Li, DDS,MSD,PhD

Role: PRINCIPAL_INVESTIGATOR

Loma Linda University, School of Dentistry

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Loma Linda University, School of Dentistry

Loma Linda, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Locker D. Xerostomia in older adults: a longitudinal study. Gerodontology. 1995 Jul;12(1):18-25. doi: 10.1111/j.1741-2358.1995.tb00125.x.

Reference Type BACKGROUND
PMID: 8626175 (View on PubMed)

Fox PC. Management of dry mouth. Dent Clin North Am. 1997 Oct;41(4):863-75.

Reference Type BACKGROUND
PMID: 9344281 (View on PubMed)

Guijarro Guijarro B, Lopez Sanchez AF, Hernandez Vallejo G. Treatment of xerostomia. A review. Med Oral. 2001 Jan-Feb;6(1):7-18. English, Spanish.

Reference Type BACKGROUND
PMID: 11488135 (View on PubMed)

Fontana M, Zunt S, Eckert GJ, Zero D. A screening test for unstimulated salivary flow measurement. Oper Dent. 2005 Jan-Feb;30(1):3-8.

Reference Type BACKGROUND
PMID: 15765951 (View on PubMed)

Andersson G, Johansson G, Attstrom R, Edwardsson S, Glantz PO, Larsson K. Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology. 1995 Jul;12(1):12-7. doi: 10.1111/j.1741-2358.1995.tb00124.x.

Reference Type BACKGROUND
PMID: 8626174 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EM-11-050038

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Study New Gel for Xerostomia
NCT04184908 UNKNOWN PHASE1
Study for the Prevention of Oral Mucositis (SPOM)
NCT05338398 UNKNOWN PHASE1/PHASE2
Green Tea Lozenges for the Management of Dry Mouth
NCT01647737 COMPLETED PHASE1/PHASE2